Les lois nationales de contrôle des drogues permettent-elles l’utilisation des opioïdes à des fins médicales et scientifiques?

Ce rapport détermine si les lois nationales de contrôle des drogues assurent la disponibilité des opioïdes à des fins médicales et scientifiques.

Pour en savoir plus, veuillez lire les informations ci-dessous (en anglais).

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

In a report to the United Nations, the International Narcotics Control Board (INCB) stated:

One of the fundamental objectives of the international drug control treaties is to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes and to promote the rational use of narcotic drugs and psychotropic substances.

Countries that signed the 1961 Single Convention on Narcotic Drugs as Amended by the 1972 Protocol, hereafter referred to as the Single Convention, are expected to abide by the Convention’s provisions on the control of certain drugs while ensuring that these drugs are available for medical purposes. The Single Convention established a medicolegal principle of balance: governments have a dual obligation to prevent the diversion and abuse of narcotic drugs and to ensure adequate provision of opioid analgesics for legitimate medical and scientific purposes.

In this paper, we use the word “balance” in the way it is used by international organizations, such as the United Nations Economic and Social Council, the INCB, the World Health Organization (WHO) and the Commission on Narcotic Drugs.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.